Further to letter dated December 06, 2019, Granules India has informed that, the company had conducted detailed analysis of its Metformin Hydrochloride for N-Nitrosodimethylamine (NDMA). It was concluded from the results that NDMA is absent in Metformin Hydrochloride batches produced by Granules. This was informed to the EU authorities.
The above information is a part of company’s filings submitted to BSE.